Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Leung

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
The Korean Journal of Hepatology|October 7, 2010
Forty-eight weeks treatment with clevudine 30 mg qd versus lamivudine 100 mg qd for chronic hepatitis B infection: a double-blind randomized studyGeorge K K Lau, Nancy Leung
Intervirology|September 17, 2005
Viral hepatitis C in Hong KongNancy Leung, Carol Chu, John S Tam
International Journal of Nanomedicine|August 28, 2007
Pegylated interferon alpha-2a (40 kDa) in the treatment of chronic hepatitis BLawrence Lai, Chee-Kin Hui, Nancy Leung, et al.
Journal of Gastroenterology and Hepatology|February 27, 2003
Asian-Pacific consensus statement on the management of chronic hepatitis B: an updateYun-Fan Liaw, Nancy Leung, Richard Guan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2005
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 updateYun-Fan Liaw, Nancy Leung, Richard Guan, et al.
Hepatology International|August 12, 2009
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 updateYun-Fan Liaw, Nancy Leung, Jia-Horng Kao, et al.
Hepatology (Baltimore, Md.)|July 14, 2007
Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phaseChee-Kin Hui, Nancy Leung, Siu-Tsan Yuen, et al.
Gastroenterology|December 31, 2003
Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virusRobert Perrillo, Hie-Won Hann, David Mutimer, et al.
Journal of Clinical Gastroenterology|March 18, 2008
Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complicationsChee-Kin Hui, Nancy Leung, Wai-Hung Shek, et al.
Gastroenterology|August 9, 2005
A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis BChing-Lung Lai, Nancy Leung, Eng-Kiong Teo, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
The Korean Journal of Hepatology|October 7, 2010
Forty-eight weeks treatment with clevudine 30 mg qd versus lamivudine 100 mg qd for chronic hepatitis B infection: a double-blind randomized studyGeorge K K Lau, Nancy Leung
Intervirology|September 17, 2005
Viral hepatitis C in Hong KongNancy Leung, Carol Chu, John S Tam
International Journal of Nanomedicine|August 28, 2007
Pegylated interferon alpha-2a (40 kDa) in the treatment of chronic hepatitis BLawrence Lai, Chee-Kin Hui, Nancy Leung, et al.
Journal of Gastroenterology and Hepatology|February 27, 2003
Asian-Pacific consensus statement on the management of chronic hepatitis B: an updateYun-Fan Liaw, Nancy Leung, Richard Guan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2005
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 updateYun-Fan Liaw, Nancy Leung, Richard Guan, et al.
Hepatology International|August 12, 2009
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 updateYun-Fan Liaw, Nancy Leung, Jia-Horng Kao, et al.
Hepatology (Baltimore, Md.)|July 14, 2007
Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phaseChee-Kin Hui, Nancy Leung, Siu-Tsan Yuen, et al.
Gastroenterology|December 31, 2003
Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virusRobert Perrillo, Hie-Won Hann, David Mutimer, et al.
Journal of Clinical Gastroenterology|March 18, 2008
Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complicationsChee-Kin Hui, Nancy Leung, Wai-Hung Shek, et al.
Gastroenterology|August 9, 2005
A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis BChing-Lung Lai, Nancy Leung, Eng-Kiong Teo, et al.
Pageof 4